- Home
- PHAR vs ZKH Comparison
PHAR vs ZKH Comparison
Compare PHAR & ZKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- ZKH
- Stock Information
- Founded
- PHAR 1988
- ZKH 1998
- Country
- PHAR Netherlands
- ZKH China
- Employees
- PHAR N/A
- ZKH N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- ZKH
- Sector
- PHAR Health Care
- ZKH
- Exchange
- PHAR Nasdaq
- ZKH Nasdaq
- Market Cap
- PHAR 718.1M
- ZKH 496.1M
- IPO Year
- PHAR N/A
- ZKH 2023
- Fundamental
- Price
- PHAR $10.27
- ZKH $3.15
- Analyst Decision
- PHAR Strong Buy
- ZKH Buy
- Analyst Count
- PHAR 3
- ZKH 1
- Target Price
- PHAR $30.00
- ZKH $4.00
- AVG Volume (30 Days)
- PHAR 4.3K
- ZKH 22.1K
- Earning Date
- PHAR 07-31-2025
- ZKH 08-21-2025
- Dividend Yield
- PHAR N/A
- ZKH N/A
- EPS Growth
- PHAR N/A
- ZKH N/A
- EPS
- PHAR N/A
- ZKH N/A
- Revenue
- PHAR $320,708,000.00
- ZKH $1,217,705,644.00
- Revenue This Year
- PHAR $13.31
- ZKH $11.72
- Revenue Next Year
- PHAR $7.68
- ZKH $10.57
- P/E Ratio
- PHAR N/A
- ZKH N/A
- Revenue Growth
- PHAR 24.13
- ZKH 2.24
- 52 Week Low
- PHAR $6.65
- ZKH $2.50
- 52 Week High
- PHAR $12.61
- ZKH $4.10
- Technical
- Relative Strength Index (RSI)
- PHAR 48.21
- ZKH 54.57
- Support Level
- PHAR $10.46
- ZKH $3.02
- Resistance Level
- PHAR $11.49
- ZKH $3.18
- Average True Range (ATR)
- PHAR 0.37
- ZKH 0.17
- MACD
- PHAR -0.12
- ZKH -0.00
- Stochastic Oscillator
- PHAR 27.62
- ZKH 80.00
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About ZKH ZKH Group Limited each representing thirty-five (35)
ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.